IPDDL in collaboration with Deloitte are launching a report on the cost-effectiveness model for laboratory testing in Poland. It combines both medical and economic perspectives and it is based on a full set of data from representative statistical groups, macroeconomic analysis and forecast models. The report is the first of its kind in Poland and will be published on the IPDDL website (please click here) during MedTech Week 2017.
WARSAW, 20 June: REPORT: LABORATORY MEDICINE IN POLAND - COST-EFFECTIVENESS
This report presents the results of more than two years of work of the Chamber of Producers and Distributors of Laboratory Diagnostics (PDDL) and Deloitte Consulting and is unique for several reasons on the Polish market and the world.
It is the first such interdisciplinary study combining medical knowledge and economics. It uses multiple sources of information and data, with a conservative approach to estimates and analyse the impact of laboratory diagnostics for five disease entities, and for two of them presents econometric models and cost-effectiveness analysis.
We hope that the detailed analysis presented in the report will be inspirational material in the shaping of health policy for the responsible individuals and institutions.
Conclusions and recommendations indicate an increased benefit for the patient and the health system, which bring the deficit reduction performed tests, expanding the amount of diagnostic information in medical decisions and increase the potential of medical diagnostic laboratories.
In the case of interest in the full version of the report, please contact the office IPDDL e-mail: firstname.lastname@example.org
Check out more at #MedTechWeek!